1-3 of 3
Andrea Anampa-Guzmán
Close
Sort by
Journal Articles

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Kaitlin Annunzio, Natalie S. Grover, Rina Li Welkie, Pallawi Torka, Marcus P. Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S. Oh, Heather Reves, Daniel Jones, Walter Hanel, Beth Christian, Praveen Ramakrishnan Geethakumari, Reem Karmali, Stefan K. Barta, Nancy L. Bartlett, Adam J. Olszewski, Narendranath Epperla
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6839–6843.
https://doi.org/10.1182/bloodadvances.2023011288
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea, Timothy S. Oh, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Irl Brian Greenwell, Emily Hansinger, Elvira Umyarova, Kaitlin Annunzio, Yazeed Sawalha, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Natalie S. Grover, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5038–5046.
https://doi.org/10.1182/bloodadvances.2023010133
Published: 2023
Includes: Supplemental data
Journal Articles

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL

Clinical Trials & Observations
Pallawi Torka, Adrienne Groman, Jerry Wong, Jenna Nichols, Angela Kader, Cory Mavis, Andrea Anampa-Guzmán, Sheila Jani Sait, AnneMarie Block, Eugene Przespolewski, Alice Mohr, Ian Lund, Kenneth McWhite, Jessica Kostrewa, Joseph DeMarco, Michael Johnson, Andrea Darrall, Roshneke Thomas, Suchitra Sundaram, Paola Ghione, Alan Hutson, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1146–1155.
https://doi.org/10.1182/bloodadvances.2022008543
Published: 2023
Includes: Supplemental data